Characterization of the thermosensitive ts453 reovirus mutant: Increased dsRNA binding of σ3 protein correlates with interferon resistance

Virology

Volumn 246, Issue 2, 1998, Pages 199-210

  Bergeron, Josée ^a   Mabrouk, Taoufik ^a   Garzon, Simon ^a   Lemay, Guy ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

AMINO ACID SUBSTITUTION; ARTICLE; DRUG RESISTANCE; GENE SEQUENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; REOVIRUS; STRUCTURE ACTIVITY RELATION; TEMPERATURE SENSITIVE MUTANT; VIRUS MUTATION; VIRUS RESISTANCE;

MIRIDAE; REOVIRUS SP.; RNA VIRUSES;

EID: 0032486592     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9188     Document Type: Article

References (71)

1. Amerongen H. M., Wilson G. R., Fields B. N., Neutra M. R. Proteolytic processing of reovirus is required for adherence to intestinal M cells. J. Virol. 68:1994;8428-8432.
2. Bass D. M., Bodkin D., Dambrauskas R., Trier J. S., Fields B. N., Wolf J. L. Intraluminal proteolytic activation plays an important role in replication of type 1 reovirus in the intestines of neonatal mice. J. Virol. 64:1990;1830-1833.
3. Beattie E., Denzler K. L., Tartaglia J., Perkus M. E., Paoletti E., Jacobs B. L. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 69:1995;499-505.
4. Bodkin D. K., Nibert M. L., Fields B. N. Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice. J. Virol. 63:1989;4676-4681.
5. Borsa J., Sargent M. D., Copps T. P., Long D. G., Chapman J. D. Specific monovalent cation effects on modification of reovirus infectivity by chymotrypsin digestionin vitro. J. Virol. 11:1973;1017-1019.
6. Borsa J., Morash B. D., Sargent M. D., Copps T. P., Lievaart P. A., Szekely J. G. Two modes of entry of reovirus particles into L cells. J. Gen. Virol. 45:1979;161-170.
7. Chaly N., Johnstone M., Hand R. Alterations in nuclear structure and function in reovirus-infected cells. Clin. Invest. Med. 2:1980;141-152.
8. Chang H.-W., Jacobs B. L. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA. 89:1992;4825-4829.
9. Chou P. Y., Fasman G. D. Prediction of protein conformation. Biochemistry. 13:1974;222-245.
10. Cross R. K., Fields B. N. Temperature-sensitive mutants of reovirus type 3: Studies on the synthesis of viral RNA. J. Virol. 50:1972;799-809.
11. Danis C., Garzon S., Lemay G. Further characterization of the ts453 mutant of mammalian orthoreovirus serotype 3 and nucleotide sequence of the mutated S4 gene. Virology. 190:1992;494-498.
12. Danis C., Lemay G. Protein synthesis in different cell lines infected with orthoreovirus serotype 3: Inhibition of host-cell protein synthesis correlates with accelerated viral multiplication and cell killing. Biochem. Cell Biol. 71:1993;81-85.
13. DeBenedetti A., Williams G. J., Baglioni C. Inhibition of binding to initiation complexes of nascent reovirus mRNA by double-stranded RNA-dependent protein kinase. J. Virol. 54:1985;408-413.
14. Deng W. P., Nickoloff J. A. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200:1992;81-88.
15. Denzler K. L., Jacobs B. L. Site-directed mutagenic analysis of the reovirus sigma3 protein binding to double-stranded RNA. Virology. 204:1994;190-199.
16. Follet E. A., Pringle C. R., Pennington T. H. Virus development in enucleated cells: echovirus, poliovirus, pseudorabies virus, reovirus, respiratory syncytial virus and Semliki forest virus. J. Gen. Virol. 26:1975;183-196.
17. Garnier J., Osguthorpe D. J., Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. Mol. Biol. 120:1978;97-120.
18. Giantini M., Shatkin A. J. Stimulation of chloramphenicol acetyltransferase mRNA translation by reovirus capsid polypeptide sigma 3 in cotransfected COS cells. J. Virol. 63:1989;2415-2421.
19. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
20. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;151-157.
21. Green S. R., Mathews M. B. Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI. Genes Dev. 6:1992;2478-2490.
22. Gupta S. L., Holmes S. L., Mehra L. L. Interferon action against reovirus: Activation of interferon-induced protein kinase in mouse L929 cells upon reovirus infection. Virology. 120:1982;495-499.
23. Hovanessian A. G. Interferon-induced dsRNA-activated protein kinase: Antiproliferative, antiviral and antitumoral functions. Semin. Virol. 4:1993;237-246.
24. Huismans H., Joklik W. K. Reovirus coded polypeptides in infected cells: Isolation of two native monomeric polypeptides with affinity for single-stranded and double-stranded RNA, respectively. Virology. 70:1976;411-424.
25. Imani F., Jacobs B. L. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein. Proc. Natl. Acad. Sci. USA. 85:1988;7887-7891.
26. Jacobs B. L., Ferguson R. E. The Lang strain of reovirus serotype 1 and the Dearing strain of reovirus serotype 3 differ in their sensitivities to beta interferon. J. Virol. 65:1991;5102-5104.
27. Jeffrey I. W., Kadereit S., Meurs E. F., Metzger T., Bachmann M., Schwemmle M., Hovanessian A. G., Clemens M. J. Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. Exp. Cell Res. 218:1995;17-27.
28. Joklik W. K. Studies on the effect of chymotrypsin on reovirions. Virology. 49:1972;700-715.
29. Katze M. G. The war against the interferon-induced dsRNA-activated protein kinase: Can viruses win. J. Interf. Res. 12:1992;241-248.
30. Katze M. G. Games viruses play: A strategic initiative against the interferon-induced dsRNA-activated 68,000 Mr protein kinase. Semin. Virol. 4:1993;259-268.
31. King R. W., Simon E. H. The virion of mengovirus contains anti-interferon activity. J. Interferon Res. 13:1993;1-7.
32. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
33. Leahy P., Carmichael G. G., Rossomando E. F. Effects of ethanol concentration and incubation period at 65°C on Cat activity in mammalian cell extracts. BioTechniques. 19:1995;894.
34. Lemay G., Millward S. Expression of the cloned S4 gene of reovirus serotype 3 in transformed eucaryotic cells: Enrichment of the viral protein in the crude initiation factor fraction. Virus Res. 6:1986;133-140.
35. Lemieux R., Lemay G., Millward S. The viral protein sigma 3 participates in translation of late viral mRNA in reovirus-infected L cells. J. Virol. 61:1987;2472-2479.
36. Lloyd R. M., Shatkin A. J. Translational regulation by reovirus polypeptide ς3: Substitution for VAI RNA and inhibition of phosphorylation of the α subunit of eukaryotic initiation factor 2. J. Virol. 66:1992;6878-6884.
37. Mabrouk T., Lemay G. Mutations in a CCHC zinc-binding motif of the reovirus ς3 protein decrease its intracellular stability. J. Virol. 68:1994a;5287-5290.
38. Mabrouk T., Lemay G. The sequence similarity of reovirus ς3 protein to picornaviral proteases is unrelated to its role in μ1 viral protein cleavage. Virology. 202:1994b;615-620.
39. Mabrouk T., Danis C., Lemay G. Two basic motifs of reovirus ς3 protein are involved in double-stranded RNA binding. Biochem. Cell Biol. 73:1995;137-145.
40. Martin P. E. M., McCrae M. A. Analysis of the stimulation of reporter gene expression by the sigma3 protein of reovirus in co-transfected cells. J. Gen. Virol. 74:1993;1055-1062.
41. McCormack S. J., Thomis D. C., Samuel C. E. Mechanism of interferon action: Identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/elF-2 alpha protein kinase. Virology. 188:1992;47-56.
42. McIntyre M. C., Frattini M. G., Grossman S. R., Laimins L. A. Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motif for zinc binding, dimerization, and transformation but not for Rb binding. J. Virol. 67:1993;3142-3150.
43. Metcalf P., Cyrklaff M., Adrian M. The three-dimensional structure of reovirus obtained by cryo-electron microscopy. EMBO J. 10:1991;3129-3136.
44. Miller F. E., Samuel C. E. Proteolytic cleavage of the reovirus sigma 3 protein results in enhanced double-stranded RNA-binding activity: Identification of a repeated basic amino acid motif within the C-terminal binding region. J. Virol. 66:1992;5347-5356.
45. Miyamoto N. G., Samuel C. E. Mechanism of interferon action: Interferon-mediated inhibition of reovirus mRNA translation in the absence of detectable mRNA degradation but in the presence of protein phosphorylation. Virology. 107:1980;461-475.
46. Morgan E. M., Zweerink H. J. Reovirus morphogenesis: Core-like particles in cells infected at 39 degrees with wild-type reovirus and temperature sensitive mutants of groups B and G. Virology. 59:1974;556-565.
47. Mustoe T. A., Ramig R. F., Sharpe A. H., Fields B. N. A genetic map of reovirus. III. Assignment of the double-stranded RNA mutant groups A, B, and G to genome segments. Virology. 85:1978;545-556.
48. Nibert M. L., Furlong D. B., Fields B. N. Mechanisms of viral pathogenesis: Distinct forms of reoviruses and their roles during replication in cells and host. J. Clin. Invest. 88:1991;727-734.
49. Nibert M. L., Schiff L. A., Fields B. N. Reoviruses and their replication. Fundamental Virology. 1996;Lippincott-Raven, Philadelphia. p. 691-730.
50. Nilsen T. W., Maroney P. A., Baglioni C. Inhibition of protein synthesis in reovirus-infected HeLa cells with elevated levels of interferon-induced protein kinase activity. J. Biol. Chem. 257:1982;14593-14596.
51. Porath J., Carlsson J., Olsson I., Belfrage G. Metal chelate affinity chromatography, a new approach to protein fractionation. Nature. 258:1975;598-599.
52. Ramig R., Fields B. N. Genetics of reovirus. Joklik W. K. The Reoviridae. 1983;197-228 Plenum, New York.
53. Reed L. J., Muench H. A simple method for estimating fifty per cent endpoints. Am. J. Hyg. 27:1938;493-497.
54. Samuel C. E. Antiviral actions of interferon: Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology. 183:1991;1-11.
55. Schiff L. A., Nibert M. L., Co M. S., Brown E. G., Fields B. N. Distinct binding sites for zinc and double-stranded RNA in the reovirus outer capsid protein sigma 3. Mol. Cell. Biol. 8:1988;273-283.
56. Schmechel S., Chute M., Skinner P., Anderson R., Schiff L. Preferential translation of reovirus mRNA by a ς3-dependent mechanism. Virology. 232:1997;62-73.
57. Seliger L. S., Giantini M., Shatkin A. J. Translational effects and sequence comparisons of the three serotypes of the reovirus S4 gene. Virology. 187:1992;202-210.
58. Shepard D. A., Ehnstrom J. G., Schiff L. A. Association of reovirus outer capsid protein ς3 and μ1 causes a conformational change that renders ς3 protease sensitive. J. Virol. 69:1995;8180-8184.
59. Shepard D. A., Ehnstrom J. G., Skinner P. J., Schiff L. A. Mutations in the zinc-binding motif of the reovirus capsid protein ς3 eliminate its ability to associate with capsid protein μ1. J. Virol. 70:1996;2065-2068.
60. Shing M., Coombs K. M. Assembly of the reovirus outer capsid requires μ1/ς3 interactions which are prevented by misfolded ς3 protein in temperature-sensitive mutant tsG453. Virus Res. 46:1996;19-29.
61. Smith R. E., Zweerink H. J., Joklik W. K. Polypeptide components of virions, top component and cores of reovirus 3. Virology. 89:1969;791-810.
62. Studier F. W., Rosenberg A. H., Dunn J. J., Dubendorff J. W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:1990;60-89.
63. Sturzenbecker L. J., Nibert M., Furlong D., Fields B. N. Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J. Virol. 61:1987;2351-2361.
64. Tillotson L., Shatkin A. J. Reovirus polypeptide sigma 3 and N-terminal myristoylation of polypeptide mu1 are required for site-specific cleavage to mu1c in transfected cells. J. Virol. 66:1992;2180-2186.
65. Towbin H., Staehelin T., Gordon J. Electrotransfer of proteins from polyacrylamide gel to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
66. Wang Q., Bergeron J., Mabrouk T., Lemay G. Site-directed mutagenesis of the double-stranded RNA binding domain of bacterially expressed ς3 protein. Virus Res. 41:1996;141-151.
67. Wiebe M. E., Joklik W. K. The mechanism of inhibition of reovirus replication by interferon. Virology. 66:1975;229-240.
68. Yue Z., Shatkin A. J. Regulated, stable expression and nuclear presence of reovirus double-stranded RNA-binding protein ς3 in HeLa cells. J. Virol. 70:1996;3497-3501.
69. Yue Z., Shatkin A. J. Double-stranded RNA-dependent protein kinase (PKR) is regulated by reovirus structural proteins. Virology. 234:1997;364-371.
70. Yuwen H., Cox J. H., Yewdell J. W., Bennink J. R., Moss B. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology. 195:1993;732-744.
71. Zarbl H., Millward S. The reovirus multiplication cycle. Joklik W. K. The Reoviridae. 1983;197-228 Plenum, New York.